Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs72725959 | chr14:74576048 | A/G | 5.67E-7 | 175 | 25.4 | 27.43 | 7.4 | KM Plot |
PCPG | rs72763622 | chr1:244158180 | G/A | 2.93E-5 | 174 | 27.47 | 20.17 | 9.48 | KM Plot |
PCPG | rs72763623 | chr1:244158352 | G/C | 2.93E-5 | 174 | 27.47 | 20.17 | 9.48 | KM Plot |
PCPG | rs72774968 | chr2:2741684 | C/G | 3.17E-5 | 174 | 25.67 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774971 | chr2:2746932 | G/A | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774972 | chr2:2747133 | C/T | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774974 | chr2:2748946 | G/A | 4.24E-5 | 171 | 25.47 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774975 | chr2:2748955 | G/A | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774977 | chr2:2750446 | G/A | 3.68E-5 | 172 | 25.67 | 23.43 | 21.68 | KM Plot |
PCPG | rs72774980 | chr2:2750553 | G/A | 3.68E-5 | 172 | 25.67 | 23.43 | 21.68 | KM Plot |
PCPG | rs7279648 | chr21:38480363 | C/T | 5.36E-6 | 176 | 25.17 | 25.87 | 3.7 | KM Plot |
PCPG | rs72797610 | chr16:85226678 | A/T | 1.73E-7 | 170 | 25.67 | 24.23 | 17.43 | KM Plot |
PCPG | rs72797612 | chr16:85228281 | A/C | 6.0E-5 | 170 | 25.47 | 32.6 | 15.8 | KM Plot |
PCPG | rs72797752 | chr16:71589107 | C/T | 1.06E-5 | 173 | 24.85 | 30.93 | 14.5 | KM Plot |
PCPG | rs72797754 | chr16:71594435 | G/T | 1.06E-5 | 173 | 24.85 | 30.93 | 14.5 | KM Plot |